Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa

AIDS Patient Care and STDs

Volumn 25, Issue 1, 2011, Pages 53-59

  Dahab, Maysoon ^a,b,c   Kielmann, Karina ^a   Charalambous, Salome ^b   Karstaedt, Alan S ^d   Hamilton, Robin ^b   La Grange, Lettie ^e   Fielding, Katherine L ^a   Churchyard, Gavin J ^a,b,c   Grant, Alison D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b AURUM INSTITUTE   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Anglo Platinum South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; QUESTIONNAIRE; SOCIAL DISCRIMINATION; SOUTH AFRICA;

ADULT; ANTI-HIV AGENTS; COMMUNITY HEALTH SERVICES; DATA COLLECTION; HIV INFECTIONS; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SOUTH AFRICA; WORKPLACE;

EID: 78651332761     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0140     Document Type: Article

References (23)

1. WHO, UNAIDS, UNICEF. Towards Universal Access-Scaling up Priority HIV/AIDS interventions in the health sector: Progress Report 2009. 2009.
2. Rosen S, Fox M, Gill C. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic re-view. PLoS Med 2007;5:e298.
3. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr 2004;35:320-323.
4. Gill C, Hamer D, Simon J, Thea D, Sabin L. No room for complacency about adherence to antiretroviral therapy in sub-saharan Africa. AIDS 2005;19:1243-1249.
5. Dahab M, Charalambous S, Karstaedt AS, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: A cohort study. BMC Public Health 2010;10:430.
6. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet 2006;367:1335-1342.
7. Badri M, Lawn SD, Wood R. Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: A longitudinal study. Lancet 2006;368:1254-1259.
8. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health 2009;14:722-731.
9. Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, Silveira VL. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil. Braz J Med Biol Res 2002;35:1173-1181.
10. Ramadhani HO, Thielman NM, Landman KZ, et al. Pre-dictors of incomplete adherence, virologic failure, and anti-viral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007;45: 1492-1498.
11. Molassiotis A, Nahas-Lopez V, Chung WYR, Lam SWC, Li CKP, Lau TFJ. Factors associated with adherence to anti-retroviral medication in HIV infected patients. Int J STD AIDS 2002;13:301-310.
12. Dlamini PS, Wantland D, Makoae LN, et al. HIV stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care STDs 2009;23:377-387.
13. Dickinson D. Managing HIV/AIDS in the South African workplace: Just another duty? S Afr J Econ Manage Sci 2003;6:25-49.
14. Gilbert L, Walker L. "They (ARVs) are my life, without them I'm nothing"\Experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place 2009;15:1123-1129.
15. Dalal R, MacPhail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an anti-retroviral treatment clinic in Johannesburg, South Africa. Epidemiol Soc Sci 2008;47:101-107.
16. Dahab M, Charalambous S, Hamilton R, et al. "That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health 2008;18:63.
17. Babb DA, Pemba L, Seatlanyane P, Charalambous S, Churchyard GJ, Grant AD. Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychol Health Med 2007;12: 314-320.
18. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 2008;67: 301-310.
19. Schneider H, Fassin D. Denial and defiance: a socio-political analysis of AIDS in South Africa. AIDS 2002;16:S45-S51.
20. Fassin D. When Bodies Remember: Experiences and Politics of AIDS in South Africa. London: University of California Press, 2007.
21. Green J, Thorogood N. Qualitative Methods for Health Re-search, 1st ed. London: Sage Publications, 2004.
22. Campbell C. Migrancy, masculine identities and AIDS: The psychosoical context of HIV transmission on the South Af-rican gold mines. Soc Sci Med 1997;42:273-281.
23. Jaffar S, Amuron B, Foster S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: A cluster-randomised equivalence trial. Lancet 2009;374:2080-2089.